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with reoperation,10 carotid angioplasty and stenting
(CAS) has been suggested as an alternative to operative
management and offers the benefits of no incision,
increased patient acceptance, and comparability of
results.11-15 Complicating this consideration is the con-
cern regarding the safety of guidewire placement and bal-
loon dilatation at the site of a previous arterial suture line,
whether from primary closure or patch angioplasty with a
synthetic or autologous patch.16
We have reviewed a consecutive series of CAS proce-
dures in which the indication for intervention was symp-
tomatic or asymptomatic high-grade restenosis after prior
CEA. We have categorized the surgical technique for clo-
sure of the carotid arteriotomy during CEA as primary
closure and autologous or synthetic patch angioplasty in
evaluation of potential complications.
METHODS
During the period from September 1996 to January
2001, 72 CAS procedures were performed with a proto-
col as outlined. Information was prospectively collected
regarding symptomatic status, degree of stenosis, and
characteristics of prior operations, including the interval of
time between CEA and CAS. Fifty-four of these proce-
dures (75%) were performed for restenosis after prior CEA
Carotid endarterectomy (CEA) is currently the pre-
ferred treatment for symptomatic and asymptomatic
extracranial carotid occlusive disease.1-5 Symptomatic or
asymptomatic carotid restenosis after CEA is relatively
uncommon and generally has been attributed to myointi-
mal hyperplasia during the early postoperative period
(within 24 to 36 months) or to recurrent atherosclerosis
thereafter.6-10 However, intervention for high-grade
(>80%) restenosis is controversial because the reported
rate of risk of stroke or total occlusion is low.6 Conversely,
the reported risk of postoperative neurologic events and
cranial nerve palsies is increased as compared with primary
CEA.7-9 Although some authors report improved results
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Objective: Carotid angioplasty and stenting (CAS) has been recommended by some authors for the management of post-
endarterectomy restenosis. However, some authors have expressed concern about the influence of primary closure and
patch angioplasty performed during carotid endarterectomy (CEA) on the incidence rate of complications after CAS.
Methods: We analyzed our consecutive series of 54 CAS procedures performed for restenosis after prior CEA. These pro-
cedures accounted for 75% of the 72 CAS procedures performed at our institution for all indications during the last 4
years. Of these 54 patients, 28 (52%) were men and 26 (48%) were women, with a mean age of 69 years. The mean
clinical follow-up period was 18 months (range, 1 to 48 months). The mean interval between prior CEA and CAS was
16 months (range, 6 to 62 months). Nineteen patients were symptomatic (35%), and 35 were asymptomatic (65%). The
mean severity of restenosis was 84% ± 7% (standard deviation). The mean residual stenosis after CAS was 8% ± 3% (stan-
dard deviation).
Results: Among the 54 prior CEAs, eight cases were performed with primary closure (15%), five procedures used patch
closure with autologous vein (9%), and 41 operations used Dacron patch closures (76%). All patients were managed
successfully with CAS with predeployment angioplasty with low profile balloons, self-expanding stents, and poststent
angioplasty to approximate the transverse diameter of the carotid artery. No instances of contrast extravasation, arter-
ial disruption, or subintimal dissection were observed. One stroke (1.8%), a retinal infarction with partial field of vision
loss, occurred in a patient with prior CEA and Dacron patch closure, and no deaths were observed in the series.
Conclusion: Performance of CAS for restenosis after CEA with autologous or synthetic patch angioplasty was techni-
cally successful in all 54 procedures. The method of closure of the arteriotomy during CEA, primary closure or patch
angioplasty, did not influence the incidence of complications. (J Vasc Surg 2002;35:435-8.)
in 28 men and 26 women, with a mean age of 69 years.
Cases in which the CAS procedure was performed for
indications other than restenosis have been excluded from
this report.
The patients underwent treatment with aspirin and
clopidogrel bisulfate. A description of our endovascular
technique has been published previously.11 Standard ret-
rograde access was performed in the common femoral
artery, and a 6F vascular sheath was inserted. Weight-
adjusted heparin was administered (70 U/kg), and the
activated clotting time was maintained at 225 to 250 sec-
onds throughout the procedure. A 0.035-inch guidewire
(Wholey modified J, 175-cm, Mallinkrodt, St Louis, Mo)
in a 5F Vitek cerebral diagnostic catheter (Cook,
Bloomington, Ind) was introduced for selective cannula-
tion of the common carotid artery. Digital angiography
was performed in the lateral, anteroposterior, and oblique
planes as required to clarify the severity of stenosis (Fig 1).
Subsequently, the diagnostic catheter was exchanged over
the 0.035-inch exchange-length (260 cm) Amplatz Super
Stiff guidewire (Meditech/Boston Scientific, Natick,
Mass) for an 8F or 6F 100 cm–long sheath, which was
passed into the common carotid artery. Self-expandable
stents were used, except in one case in which a short 
balloon expandable stent was used at the apex of a
Wallstent to correct an intimal defect. The stenosis was
crossed with a 0.018-inch Roadrunner extra-support
guidewire (Cook) for the Wallstent (Meditech/Boston
Scientific, Minneapolis, Minn) cases and the one Palmaz
stent (Johnson and Johnson Interventional Systems Co,
Warren, NJ) case, and a 0.014-inch guidewire was used for
the ACCULINK (Guidant, Hi-Torque Floppy, Menlo
Park, Calif) cases. In two cases, an antiembolic distal filter
device (ACCUNET, Guidant) was used (Fig 2) as part of
a Food and Drug Administration approval feasibility trial.
Precise torque control was required to ensure free move-
ment of the tip of the guidewire as it was steered across the
stenosis. This was intended to minimize the risk of subin-
timal dissection (Fig 2). Prestent dilatation was performed
with low-profile 3 to 4 × 30-mm balloon catheters inflated
up to 8 atm followed by stent deployment. Poststent
dilatation was performed with 5-mm or 6-mm high-pres-
sure balloons inflated up to 12 atm. On completion of the
procedure, ipsilateral cervical (Fig 3) and intracranial
carotid angiography was performed to assess technical suc-
cess and to exclude distal cerebral embolization.
RESULTS
Asymptomatic high-grade restenoses (≥80%) were
managed in 35 patients (65%), and symptomatic
restenoses (≥80%) were treated in 19 patients (35%). The
symptoms consisted of amaurosis fugax (n = 1), transient
ischemic attack (n = 10), and nondisabling stroke (n = 4).
Closure of the arteriotomies with CEAs included primary
closure (n = 8; 15%), autologous patch angioplasty (n = 5;
9%), and synthetic patch closure (n = 41; 76%). The mean
interval between prior CEA and CAS was 16 months
(range, 6 to 62 months). The mean severity stenosis
before CAS was 84% ± 7% (standard deviation). All CAS
procedures (100%) were accomplished successfully. Self-
expanding Wallstents (8 × 20 mm and 10 × 20 mm) were
used in 49 CAS procedures (91%), self-expanding nickel-
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Fig 1. Selective lateral carotid angiogram results show high-grade
restenotic lesion in proximal internal carotid artery (arrow) near
apex of Dacron patch angioplasty used in this patient.
Fig 2. Selective angiogram results show passage of guidewire for
placement of self-expandable Nitinol stent. Note center location
of wire, which was confirmed during carotid angioplasty and
stenting. Antiembolic device (arrow) was used (ACCUNET,
Guidant, Menlo Park, Calif) during this procedure. 
titanium stents were used in four CAS procedures (7.5%),
and a balloon expandable stent was used in one case
(1.5%). No contrast extravasation, arterial disruption, or
subintimal dissections were observed. In one instance,
passage of an 0.018-in guidewire was suspected in a subin-
timal plane at the apex of the patch. This was apparent
because of its lack of midline position and failure to move
freely within the arterial lumen. In this instance, the wire
was retracted and passed again across the stenosis without
complication. Residual stenosis after CAS did not exceed
15% in any cases; mean residual was 8% ± 3% (standard
deviation). One stroke (1.8%), a retinal infarction with
partial field of vision loss, occurred in a patient with prior
CEA and Dacron patch closure. No deaths occurred in
this clinical series. 
DISCUSSION
Use of CAS for restenosis of the carotid artery after
prior CEA has been recommended by clinicians11-15 con-
cerned about the reported higher complication rates after
carotid reconstruction, particularly related to postopera-
tive cranial nerve palsies. Bartlett and colleagues7 reported
on a series of 116 operations for restenosis, which was
accompanied by a 4.3% stroke morbidity rate and a mor-
tality rate of 1.7%. Transient cranial nerve palsies were
observed in 23 cases (19.8%). Das and colleagues8 used
patch angioplasty for restenosis in 62 operations, with a
combined stroke and death rate of 4.6% and an incidence
rate of transient cranial nerve palsy of 9.2%. Treiman and
colleagues9 used interposition saphenous vein grafts in 57
of 162 operations for restenosis and reported a periopera-
tive stroke rate of 3.5% compared with 1.9% for second
CEAs. However, Hill et al10 recently reported operative
management of 40 restenotic lesions after CEA without
stroke or death. These contrasting results probably relate
to the retrospective nature of these analyses and the vari-
able numbers of cases reported. Comparability of compli-
cations between CAS and operative management is
suggested in the recent multiinstitutional data on CAS for
restenosis after CEA.15 Results from 14 centers (358 CAS
procedures) showed a 30-day stroke rate of 2.5% and a
mortality rate of 1.2%. As also reported by our group,11
periprocedural complications appear to be essentially com-
parable between CAS and operative intervention.
The technique for closure of the arteriotomy with
CEA has been discussed as a potential source of complica-
tions.16 In this series, patch angioplasty was used in 85% of
cases, autologous patches in 9%, and Dacron patches in
76%. In all cases, prestent deployment balloon angioplasty
was performed with low profile 3-mm and 4-mm bal-
loons. Disruption of patch angioplasties was not observed
in any cases, and no extravasations of contrast media were
noted. However, care with passage of the guidewire across
the apex of the patch angioplasty is emphasized, and inter-
ventionalists should be aware of the technique used for
closure of the carotid arteriotomy in patients with prior
CEA. For example, balloon dilatation performed over a
subintimally placed guidewire could produce occlusion of
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the internal carotid artery and lead to neurologic compli-
cations. On the basis of our experience with use of proper
guidewire and balloon precautions, however, it would
appear that performance of CAS in cases of primary or
autologous and Dacron patch closure of the arteriotomy is
safe and reliable.
In a prior publication,14 our group documented an 8%
incidence of instent restenosis during a mean follow-up
period of 18 months. In each of these cases, repeat balloon
angioplasty (n = 3) and angioplasty and stenting (n = 1)
were accomplished without complications. No further
operative interventions have been performed, and all
patients have continued to be asymptomatic. No recurrent
instent restenoses have been identified in our surveillance
program, which includes biannual duplex ultrasound scan
examinations.
In conclusion, CAS is a reasonable alternative to oper-
ative intervention and should not be associated with com-
plications related to the method of closure to the
arteriotomy at the original CEA procedure. Arguments in
favor of endovascular or operative management should be
on the basis of the individual clinician’s experience because
results are highly variable and inconclusive regarding
complications associated with operative intervention.
However, because CEA and CAS appear to have compa-
rable complications in the management of restenosis after
prior CEA, we predict increasing use of CAS for this indi-
cation. Care must be exercised in passing the guidewire
across the stenosis, suture line, or patch angioplasty.
Careful sizing of the angioplasty balloon during perfor-
mance of the procedure should preclude arterial disrup-
tion or extravasation of contrast medium, none having
been observed in this series. As use of CAS is expanded,
complications related to closure of the carotid arteriotomy
Fig 3. Final selective angiogram results showed satisfactory post-
stent result.
may be encountered. However, as our initial clinical expe-
rience has shown, these can be minimized or avoided with
use of the outlined techniques. 
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